Capital Fund Management (CFM)
ACHN

Capital Fund Management (CFM)’s Achillion Pharmaceuticals ACHN Stock Holding History

Capital Fund Management (CFM)’s Portfolio ACHN Stock Details ACHN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q4 		– Sell
-268,391
Closed -$2.17M – 1941
2016
Q3 		$2.17M Buy
+268,391
New +$2.28M 0.02% 738
2016
Q2 		– Sell
-188,003
Closed -$1.45M – 1891
2016
Q1 		$1.45M Buy
+188,003
New +$1.38M 0.01% 781
2013
Q4 		– Sell
-71,816
Closed -$217K – 1908
2013
Q3 		$217K Buy
+71,816
New +$492K ﹤0.01% 1473

Other funds holding ACHN

RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
O
OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JHIU
Janus Henderson Investors US Denver, Colorado $122B AUM 18.26% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
NI
Numeric Investors Boston, Massachusetts $13.7B AUM 28.88% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

Capital Fund Management (CFM)'s ACHN Position: Q4 2016 in Review

Capital Fund Management (CFM) sold out of Achillion Pharmaceuticals (ACHN) in Q4 2016, closing a stake of 268,391 shares — an estimated $2.17M sold.

Capital Fund Management (CFM) first reported a position in ACHN in Q3 2013 and held it in 3 quarters. The position peaked at $2.17M in Q3 2016. 140 funds tracked by Wall St. Rank hold ACHN as of Q4 2016.

  • Capital Fund Management (CFM) reported no remaining Achillion Pharmaceuticals position as of Q4 2016 after selling out during the quarter.
  • Capital Fund Management (CFM) sold 268,391 Achillion Pharmaceuticals shares in Q4 2016, an estimated $2.17M.
  • Capital Fund Management (CFM) first reported a position in Achillion Pharmaceuticals in Q3 2013 and held it in 3 quarters.
  • Capital Fund Management (CFM)'s Achillion Pharmaceuticals position peaked at $2.17M in Q3 2016.
  • 140 funds tracked by Wall St. Rank held Achillion Pharmaceuticals as of Q4 2016.

Based on Capital Fund Management (CFM)'s 13F filing for Q4 2016, filed 8 Feb 2017.